After a three-day bench trial, the court found that Lupin infringed all asserted claims and that all asserted claims were valid. However, the patents and claims ultimately litigated were ...
The drug is indicated for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of HIV-1 infection in adults and adolescents. Lupin has received approval from the ...
Global pharma major Lupin Limited on Tuesday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback